144 related articles for article (PubMed ID: 12070021)
1. Circulating and binding characteristics of wild-type factor IX and certain Gla domain mutants in vivo.
Gui T; Lin HF; Jin DY; Hoffman M; Straight DL; Roberts HR; Stafford DW
Blood; 2002 Jul; 100(1):153-8. PubMed ID: 12070021
[TBL] [Abstract][Full Text] [Related]
2. An important role for the activation peptide domain in controlling factor IX levels in the blood of haemophilia B mice.
Begbie ME; Mamdani A; Gataiance S; Eltringham-Smith LJ; Bhakta V; Hortelano G; Sheffield WP
Thromb Haemost; 2005 Dec; 94(6):1138-47. PubMed ID: 16411385
[TBL] [Abstract][Full Text] [Related]
3. Identification of the endothelial cell binding site for factor IX.
Cheung WF; van den Born J; Kühn K; Kjellén L; Hudson BG; Stafford DW
Proc Natl Acad Sci U S A; 1996 Oct; 93(20):11068-73. PubMed ID: 8855310
[TBL] [Abstract][Full Text] [Related]
4. The binding of human factor IX to endothelial cells is mediated by residues 3-11.
Cheung WF; Hamaguchi N; Smith KJ; Stafford DW
J Biol Chem; 1992 Oct; 267(29):20529-31. PubMed ID: 1400370
[TBL] [Abstract][Full Text] [Related]
5. Abnormal hemostasis in a knock-in mouse carrying a variant of factor IX with impaired binding to collagen type IV.
Gui T; Reheman A; Ni H; Gross PL; Yin F; Monroe D; Monahan PE; Stafford DW
J Thromb Haemost; 2009 Nov; 7(11):1843-51. PubMed ID: 19583826
[TBL] [Abstract][Full Text] [Related]
6. Characterization of gamma-carboxyglutamic acid residue 21 of human factor IX.
Wolberg AS; Li L; Cheung WF; Hamaguchi N; Pedersen LG; Stafford DW
Biochemistry; 1996 Aug; 35(32):10321-7. PubMed ID: 8756687
[TBL] [Abstract][Full Text] [Related]
7. The endothelial cell binding determinant of human factor IX resides in the gamma-carboxyglutamic acid domain.
Toomey JR; Smith KJ; Roberts HR; Stafford DW
Biochemistry; 1992 Feb; 31(6):1806-8. PubMed ID: 1310619
[TBL] [Abstract][Full Text] [Related]
8. gamma-Carboxyglutamic acids 36 and 40 do not contribute to human factor IX function.
Gillis S; Furie BC; Furie B; Patel H; Huberty MC; Switzer M; Foster WB; Scoble HA; Bond MD
Protein Sci; 1997 Jan; 6(1):185-96. PubMed ID: 9007991
[TBL] [Abstract][Full Text] [Related]
9. Localization of a calcium-dependent epitope to the amino terminal region of the Gla domain of human factor IX.
Cheung WF; Stafford DW; Sugo T
Thromb Res; 1996 Jan; 81(1):65-73. PubMed ID: 8747521
[TBL] [Abstract][Full Text] [Related]
10. The epidermal growth factor-like domains of factor IX. Effect on blood clotting and endothelial cell binding of a fragment containing the epidermal growth factor-like domains linked to the gamma-carboxyglutamic acid region.
Astermark J; Stenflo J
J Biol Chem; 1991 Feb; 266(4):2438-43. PubMed ID: 1989995
[TBL] [Abstract][Full Text] [Related]
11. Human factor IX binds to specific sites on the collagenous domain of collagen IV.
Wolberg AS; Stafford DW; Erie DA
J Biol Chem; 1997 Jul; 272(27):16717-20. PubMed ID: 9201971
[TBL] [Abstract][Full Text] [Related]
12. Structural determinants of the factor IX molecule mediating interaction with the endothelial cell binding site are distinct from those involved in phospholipid binding.
Ryan J; Wolitzky B; Heimer E; Lambrose T; Felix A; Tam JP; Huang LH; Nawroth P; Wilner G; Kisiel W
J Biol Chem; 1989 Dec; 264(34):20283-7. PubMed ID: 2555350
[TBL] [Abstract][Full Text] [Related]
13. The factor IX gamma-carboxyglutamic acid (Gla) domain is involved in interactions between factor IX and factor XIa.
Aktimur A; Gabriel MA; Gailani D; Toomey JR
J Biol Chem; 2003 Mar; 278(10):7981-7. PubMed ID: 12496253
[TBL] [Abstract][Full Text] [Related]
14. Role of the propeptide and gamma-glutamic acid domain of factor IX for in vitro carboxylation by the vitamin K-dependent carboxylase.
Stanley TB; Wu SM; Houben RJ; Mutucumarana VP; Stafford DW
Biochemistry; 1998 Sep; 37(38):13262-8. PubMed ID: 9748333
[TBL] [Abstract][Full Text] [Related]
15. Derivatives of blood coagulation factor IX contain a high affinity Ca2+-binding site that lacks gamma-carboxyglutamic acid.
Morita T; Isaacs BS; Esmon CT; Johnson AE
J Biol Chem; 1984 May; 259(9):5698-704. PubMed ID: 6425296
[TBL] [Abstract][Full Text] [Related]
16. The binding of natural variants of human factor IX to endothelial cells.
Mayhew M; Handford P; Brownlee GG
FEBS Lett; 1994 Mar; 341(1):74-8. PubMed ID: 8137926
[TBL] [Abstract][Full Text] [Related]
17. Inhibitors of 2-ketoglutarate-dependent dioxygenases block aspartyl beta-hydroxylation of recombinant human factor IX in several mammalian expression systems.
Derian CK; VanDusen W; Przysiecki CT; Walsh PN; Berkner KL; Kaufman RJ; Friedman PA
J Biol Chem; 1989 Apr; 264(12):6615-8. PubMed ID: 2708327
[TBL] [Abstract][Full Text] [Related]
18. Substitution of the Gla domain in factor X with that of protein C impairs its interaction with factor VIIa/tissue factor: lack of comparable effect by similar substitution in factor IX.
Ndonwi M; Broze GJ; Agah S; Schmidt AE; Bajaj SP
J Biol Chem; 2007 May; 282(21):15632-44. PubMed ID: 17387172
[TBL] [Abstract][Full Text] [Related]
19. Binding of the factor IX gamma-carboxyglutamic acid domain to the vitamin K-dependent gamma-glutamyl carboxylase active site induces an allosteric effect that may ensure processive carboxylation and regulate the release of carboxylated product.
Lin PJ; Straight DL; Stafford DW
J Biol Chem; 2004 Feb; 279(8):6560-6. PubMed ID: 14660587
[TBL] [Abstract][Full Text] [Related]
20. Effect of propeptide mutations on post-translational processing of factor IX. Evidence that beta-hydroxylation and gamma-carboxylation are independent events.
Rabiet MJ; Jorgensen MJ; Furie B; Furie BC
J Biol Chem; 1987 Nov; 262(31):14895-8. PubMed ID: 3667614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
